Compare $ALT vs $OVID | Chartloom

Compare

$ALT vs $OVID

Altimmune Inc · Ovid Therapeutics Inc

ALT

Altimmune Inc

OVID

Ovid Therapeutics Inc

Compare $ALT vs $OVID

Comparing Altimmune Inc and Ovid Therapeutics Inc

ALTAltimmune Inc

OVIDOvid Therapeutics Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

OVID

Detailed metrics comparison

ALT

Altimmune Inc

OVID

Ovid Therapeutics Inc

Market Cap

ALT$508M

OVID$459M

Enterprise Value

ALT$479M

OVID$448M

Price

ALT$2.61

OVID$2.46

P/E Ratio

ALTN/A

OVIDN/A

P/S Ratio

ALT16,373.12x

OVID290.04x

EV/Sales

ALT15,461.31x

OVID282.89x

EV/EBITDA

ALT0.00x

OVID3.65x

P/B Ratio

ALT1.12x

OVID2.21x

P/FCF Ratio

ALTN/A

OVIDN/A

EV/FCF

ALT-6.26x

OVID-8.18x

PEG Ratio

ALTN/A

OVIDN/A

Forward P/E (NTM)

ALTN/A

OVIDN/A

Forward P/S (NTM)

ALTN/A

OVID1,284.26x

Revenue (TTM)

ALT$31K

OVID$2M

Revenue Growth (YoY)

ALT55.0%

OVID-76.2%

Forward Rev Growth

ALT217.1%

OVID-72.6%

Gross Margin (TTM)

ALT0.0%

OVID0.0%

Operating Margin (TTM)

ALT0.0%

OVID0.0%

EBITDA Margin (TTM)

ALT-322987.1%

OVID-3681.4%

Net Margin (TTM)

ALT-296000.0%

OVID-2178.9%

FCF Margin (TTM)

ALT-246974.2%

OVID-3460.1%

Net Income (TTM)

ALT$-92M

OVID$-34M

FCF (TTM)

ALT$-77M

OVID$-55M

EPS (TTM)

ALT-$0.49

OVID-$0.17

ROE (TTM)

ALT-3141.0%

OVID-2364.0%

ROA (TTM)

ALT-2696.0%

OVID-2052.0%

ROIC (TTM)

ALT-2853.0%

OVID-2364.0%

Cash

ALT$63M

OVID$11M

Debt

ALT$35M

OVID$0

Net Cash/Debt

ALT$28M

OVID$11M

Current Ratio (TTM)

ALT26.78x

OVID12.39x

Quick Ratio (TTM)

ALT26.37x

OVID11.75x

Debt/Equity (TTM)

ALT0.07x

OVID0.00x

Debt/Assets (TTM)

ALT0.0%

OVID0.0%

Interest Coverage (TTM)

ALTN/A

OVIDN/A

Net Debt/EBITDA (TTM)

ALT0.00x

OVID0.00x

Beta

ALT0.06

OVID0.28

52W Performance

ALT-33.6%

OVID55.7%

YTD Performance

ALT-25.6%

OVID39.8%

% from 52W High

ALT-59.5%

OVID-20.8%

% from 52W Low

ALT2.4%

OVID108.5%

Asset Turnover (TTM)

ALT0.00x

OVID0.01x

FCF Yield (TTM)

ALT-15.1%

OVID-11.9%

Earnings Yield (TTM)

ALT-18.1%

OVID-7.5%

Dividend Yield (TTM)

ALTN/A

OVIDN/A

Rule of 40

ALT-246,919.2

OVID-3,536.3

EV/GP/RG

ALTN/A

OVIDN/A

Ticker research

View ALT research View OVID research

Metric	ALT Altimmune Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$508M	$459M
Enterprise Value	$479M	$448M
Price	$2.61	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	290.04x
EV/Sales	15,461.31x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	1.12x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1,284.26x
Revenue & Growth
Revenue (TTM)	$31K	$2M
Revenue Growth (YoY)	55.0%	-76.2%
Forward Rev Growth	217.1%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	-3681.4%
Net Margin (TTM)	-296000.0%	-2178.9%
FCF Margin (TTM)	-246974.2%	-3460.1%
Net Income (TTM)	$-92M	$-34M
FCF (TTM)	$-77M	$-55M
EPS (TTM)	-$0.49	-$0.17
ROE (TTM)	-3141.0%	-2364.0%
ROA (TTM)	-2696.0%	-2052.0%
ROIC (TTM)	-2853.0%	-2364.0%
Financial Health
Cash	$63M	$11M
Debt	$35M	$0
Net Cash/Debt	$28M	$11M
Current Ratio (TTM)	26.78x	12.39x
Quick Ratio (TTM)	26.37x	11.75x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	0.28
52W Performance	-33.6%	55.7%
YTD Performance	-25.6%	39.8%
% from 52W High	-59.5%	-20.8%
% from 52W Low	2.4%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-15.1%	-11.9%
Earnings Yield (TTM)	-18.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View OVID research

Valuation

P/S Ratio

OVID

290.04x

ALT

16,373.12x

EV/FCF

OVID

-8.18x

ALT

-6.26x

Growth & revenue

Revenue Growth TTM

ALT

55.0%

OVID

-76.2%

Forward Revenue Growth

ALT

217.1%

OVID

-72.6%

Profitability & performance

Gross Margin

ALT

0.0%

OVID

0.0%

ROE

OVID

-2364.0%

ALT

-3141.0%

FCF Yield %

OVID

-11.9%

ALT

-15.1%

52-Week Performance

OVID

55.7%

ALT

-33.6%

Detailed metrics comparison

ALT

Altimmune Inc

OVID

Ovid Therapeutics Inc

Market Cap

ALT$508M

OVID$459M

Enterprise Value

ALT$479M

OVID$448M

Price

ALT$2.61

OVID$2.46

P/E Ratio

ALTN/A

OVIDN/A

P/S Ratio

ALT16,373.12x

OVID290.04x

EV/Sales

ALT15,461.31x

OVID282.89x

EV/EBITDA

ALT0.00x

OVID3.65x

P/B Ratio

ALT1.12x

OVID2.21x

P/FCF Ratio

ALTN/A

OVIDN/A

EV/FCF

ALT-6.26x

OVID-8.18x

PEG Ratio

ALTN/A

OVIDN/A

Forward P/E (NTM)

ALTN/A

OVIDN/A

Forward P/S (NTM)

ALTN/A

OVID1,284.26x

Revenue (TTM)

ALT$31K

OVID$2M

Revenue Growth (YoY)

ALT55.0%

OVID-76.2%

Forward Rev Growth

ALT217.1%

OVID-72.6%

Gross Margin (TTM)

ALT0.0%

OVID0.0%

Operating Margin (TTM)

ALT0.0%

OVID0.0%

EBITDA Margin (TTM)

ALT-322987.1%

OVID-3681.4%

Net Margin (TTM)

ALT-296000.0%

OVID-2178.9%

FCF Margin (TTM)

ALT-246974.2%

OVID-3460.1%

Net Income (TTM)

ALT$-92M

OVID$-34M

FCF (TTM)

ALT$-77M

OVID$-55M

EPS (TTM)

ALT-$0.49

OVID-$0.17

ROE (TTM)

ALT-3141.0%

OVID-2364.0%

ROA (TTM)

ALT-2696.0%

OVID-2052.0%

ROIC (TTM)

ALT-2853.0%

OVID-2364.0%

Cash

ALT$63M

OVID$11M

Debt

ALT$35M

OVID$0

Net Cash/Debt

ALT$28M

OVID$11M

Current Ratio (TTM)

ALT26.78x

OVID12.39x

Quick Ratio (TTM)

ALT26.37x

OVID11.75x

Debt/Equity (TTM)

ALT0.07x

OVID0.00x

Debt/Assets (TTM)

ALT0.0%

OVID0.0%

Interest Coverage (TTM)

ALTN/A

OVIDN/A

Net Debt/EBITDA (TTM)

ALT0.00x

OVID0.00x

Beta

ALT0.06

OVID0.28

52W Performance

ALT-33.6%

OVID55.7%

YTD Performance

ALT-25.6%

OVID39.8%

% from 52W High

ALT-59.5%

OVID-20.8%

% from 52W Low

ALT2.4%

OVID108.5%

Asset Turnover (TTM)

ALT0.00x

OVID0.01x

FCF Yield (TTM)

ALT-15.1%

OVID-11.9%

Earnings Yield (TTM)

ALT-18.1%

OVID-7.5%

Dividend Yield (TTM)

ALTN/A

OVIDN/A

Rule of 40

ALT-246,919.2

OVID-3,536.3

EV/GP/RG

ALTN/A

OVIDN/A

Ticker research

View ALT research View OVID research

Metric	ALT Altimmune Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$508M	$459M
Enterprise Value	$479M	$448M
Price	$2.61	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	290.04x
EV/Sales	15,461.31x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	1.12x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1,284.26x
Revenue & Growth
Revenue (TTM)	$31K	$2M
Revenue Growth (YoY)	55.0%	-76.2%
Forward Rev Growth	217.1%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	-3681.4%
Net Margin (TTM)	-296000.0%	-2178.9%
FCF Margin (TTM)	-246974.2%	-3460.1%
Net Income (TTM)	$-92M	$-34M
FCF (TTM)	$-77M	$-55M
EPS (TTM)	-$0.49	-$0.17
ROE (TTM)	-3141.0%	-2364.0%
ROA (TTM)	-2696.0%	-2052.0%
ROIC (TTM)	-2853.0%	-2364.0%
Financial Health
Cash	$63M	$11M
Debt	$35M	$0
Net Cash/Debt	$28M	$11M
Current Ratio (TTM)	26.78x	12.39x
Quick Ratio (TTM)	26.37x	11.75x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	0.28
52W Performance	-33.6%	55.7%
YTD Performance	-25.6%	39.8%
% from 52W High	-59.5%	-20.8%
% from 52W Low	2.4%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-15.1%	-11.9%
Earnings Yield (TTM)	-18.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View OVID research